Research-driven biopharmaceutical developer and marketer of innovative therapeutic medicines for respiratory conditions, rare diseases, and specialized care, serving patients and healthcare professionals. R&D-backed treatments focused on improving quality of life with legally binding social and environmental commitments (Benefit Corporation/B Corp), targeting net-zero greenhouse gas emissions by 2035.